A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors

2012

Purpose To determine the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), and recommended phase II dose (RD) of elisidepsin.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

26

References

18

Citations